Stacie Griffith, MS, CCC-SLP - Medicare Speech-Language Pathologist in Adrian, MI

Stacie Griffith, MS, CCC-SLP is a medicare enrolled "Speech-language Pathologist" provider in Adrian, Michigan. She graduated from medical school in 2008 and has 16 years of diverse experience with area of expertise as Qualified Speech Language Pathologist. She is a member of the group practice 3 Dimensional Physical Therapy Llc and her current practice location is 1200 Corporate Dr, Adrian, Michigan. You can reach out to her office (for appointments etc.) via phone at (517) 264-2790.

Stacie Griffith is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1013683952.

Contact Information

Stacie Griffith, MS, CCC-SLP
1200 Corporate Dr,
Adrian, MI 49221-9008
(517) 264-2790
Not Available



Healthcare Provider's Profile

Full NameStacie Griffith
GenderFemale
SpecialityQualified Speech Language Pathologist
Experience16 Years
Location1200 Corporate Dr, Adrian, Michigan
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Stacie Griffith graduated from medical school in 2008
  NPI Data:
  • NPI Number: 1013683952
  • Provider Enumeration Date: 08/20/2021
  • Last Update Date: 08/20/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0446655989
  • Enrollment ID: I20210823001472

Medical Identifiers

Medical identifiers for Stacie Griffith such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013683952NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist (* (Not Available))Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
3 Dimensional Physical Therapy Llc983025336818

News Archive

CytRx commences INNO-206 Phase 2 clinical trial for pancreatic cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies.

Study: Electronic health records cut some costs, but may not show savings everywhere

The researchers find that adoption of electronic health records cut costs for some Massachusetts community doctors but may not reduce overall inpatient hospital costs.

Additional preclinical data on DelMar's VAL-083 to treat temozolomide-resistant GBM presented at AACR

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, presented additional preclinical data at the American Association of Cancer Research (AACR) Advances in Brain Cancer Research Conference on the potential for its lead product candidate VAL-083 (dianhydrogalactitol) to treat patients with temozolomide-resistant glioblastoma multiforme (GBM).

Researchers develop novel system to image worm brain activity

A research team at Worcester Polytechnic Institute and The Rockefeller University in New York has developed a novel system to image brain activity in multiple awake and unconstrained worms. The technology, which makes it possible to study the genetics and neural circuitry associated with animal behavior, can also be used as a high-throughput screening tool for drug development targeting autism, anxiety, depression, schizophrenia, and other brain disorders.

Nepstar declares annual cash dividend of US$0.32 per ADS

China Nepstar Chain Drugstore Ltd. ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared an annual cash dividend of US$0.32 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$31.59 million.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Stacie Griffith allows following entities to bill medicare on her behalf.
Provider Name3 Dimensional Physical Therapy Llc
Provider TypePart B Supplier - Physical/occupational Therapy Group In Private Practice
Provider IdentifiersNPI Number: 1164676730
PECOS PAC ID: 9830253368
Enrollment ID: O20090128000606

News Archive

CytRx commences INNO-206 Phase 2 clinical trial for pancreatic cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies.

Study: Electronic health records cut some costs, but may not show savings everywhere

The researchers find that adoption of electronic health records cut costs for some Massachusetts community doctors but may not reduce overall inpatient hospital costs.

Additional preclinical data on DelMar's VAL-083 to treat temozolomide-resistant GBM presented at AACR

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, presented additional preclinical data at the American Association of Cancer Research (AACR) Advances in Brain Cancer Research Conference on the potential for its lead product candidate VAL-083 (dianhydrogalactitol) to treat patients with temozolomide-resistant glioblastoma multiforme (GBM).

Researchers develop novel system to image worm brain activity

A research team at Worcester Polytechnic Institute and The Rockefeller University in New York has developed a novel system to image brain activity in multiple awake and unconstrained worms. The technology, which makes it possible to study the genetics and neural circuitry associated with animal behavior, can also be used as a high-throughput screening tool for drug development targeting autism, anxiety, depression, schizophrenia, and other brain disorders.

Nepstar declares annual cash dividend of US$0.32 per ADS

China Nepstar Chain Drugstore Ltd. ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared an annual cash dividend of US$0.32 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$31.59 million.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Stacie Griffith is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Stacie Griffith, MS, CCC-SLP
1800 W Us Highway 223 Ste 100,
Adrian, MI 49221-8439

Ph: (517) 263-3378
Stacie Griffith, MS, CCC-SLP
1200 Corporate Dr,
Adrian, MI 49221-9008

Ph: (517) 264-2790

News Archive

CytRx commences INNO-206 Phase 2 clinical trial for pancreatic cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies.

Study: Electronic health records cut some costs, but may not show savings everywhere

The researchers find that adoption of electronic health records cut costs for some Massachusetts community doctors but may not reduce overall inpatient hospital costs.

Additional preclinical data on DelMar's VAL-083 to treat temozolomide-resistant GBM presented at AACR

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing proven cancer therapies in new orphan drug indications, presented additional preclinical data at the American Association of Cancer Research (AACR) Advances in Brain Cancer Research Conference on the potential for its lead product candidate VAL-083 (dianhydrogalactitol) to treat patients with temozolomide-resistant glioblastoma multiforme (GBM).

Researchers develop novel system to image worm brain activity

A research team at Worcester Polytechnic Institute and The Rockefeller University in New York has developed a novel system to image brain activity in multiple awake and unconstrained worms. The technology, which makes it possible to study the genetics and neural circuitry associated with animal behavior, can also be used as a high-throughput screening tool for drug development targeting autism, anxiety, depression, schizophrenia, and other brain disorders.

Nepstar declares annual cash dividend of US$0.32 per ADS

China Nepstar Chain Drugstore Ltd. ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared an annual cash dividend of US$0.32 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$31.59 million.

Read more News

› Verified 2 days ago


Speech-Language Pathologist in Adrian, MI

Mrs. Emily Grace Corfman, M.A., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 777 Kimole Ln, Suite 110, Adrian, MI 49221
Phone: 517-265-0950    
Miss Shelby L Deshetler, SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 1277 E Siena Heights Dr, Adrian, MI 49221
Phone: 175-266-3641    
Mrs. Emily Grace Hendrixq, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 730 Kimole Ln, Adrian, MI 49221
Phone: 517-263-6771    
Sydney Jade Woodman, SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 1424 S Main St, Adrian, MI 49221
Phone: 517-312-1712    Fax: 517-312-1711
Megan Welker, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 700 Lakeshire Trl, Adrian, MI 49221
Phone: 517-263-0781    
Carolyn Bloomburg, MS, CF-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1424 S Main St Ste 2, Adrian, MI 49221
Phone: 517-312-1711    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.